시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 생체 재료 시장 보고서(2025년)
Biomaterials Global Market Report 2025
상품코드 : 1790775
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

생체 재료 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년 연평균 성장률(CAGR) 13.6%로 2,524억 1,000만 달러의 성장이 전망됩니다. 예측 기간의 성장은 소비자 선호도의 변화, 3D 프린팅 및 적층 제조에 대한 생체 재료의 수요 급증, 생분해성 및 생체 흡수성 생체 재료 부문의 확장, 맞춤형 의약품을 위한 약물 전달 시스템에 생체 재료의 채택, 상처 치료 및 조직 재생에 생체 재료의 사용 증가에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 반응성 및 적응성을 갖춘 스마트 생체 재료의 개발, 기능 향상을 위한 나노 기술의 통합, 맞춤형 생체 재료 솔루션으로 이어지는 정밀 의학의 강조, 해양 및 식물 유래 생체 재료 원료의 탐색, 혁신적인 용도를 위한 생체 재료 기업과 의료 기관 간의 협력 등이 있습니다.

향후 5년간 13.6%의 성장 전망은 이 시장에 대한 이전 추정치보다 0.7% 소폭 감소한 것입니다. 이러한 감소는 주로 미국과 다른 국가들 간의 관세 영향에 기인합니다. 스위스와 이스라엘에서 수입되는 특수 생체 재료에 대한 무역 장벽이 높아지면서 의료기기 제조 및 조직 공학 프로젝트가 지연되어 의료 혁신에 드는 비용이 증가함에 따라 미국에 직접적인 영향을 미칠 가능성이 높습니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 세계 경제 및 무역에 대한 부정적인 영향으로 그 영향이 더욱 광범위하게 나타날 것입니다.

심혈관 질환의 유병률이 증가하면서 생체 재료 시장의 확장이 가속화되고 있습니다. 심혈관 질환은 고혈압, 흡연, 고콜레스테롤, 운동 부족 등의 요인에 의해 발생합니다. 심혈관 질환 사례의 증가 대부분은 당뇨병, 만성 호흡기 질환, 고혈압 관련 관상동맥 질환(CAD), 심근경색 등 비전염성 질환에 기인합니다. 심장 판막, 심폐 우회 시스템, 스텐트, 혈관 이식편, 완전 인공 심장, 심박 조율기 등 생체재료는 손상되거나 질병에 걸린 심장 조직의 치유 메커니즘으로 기능합니다. 예를 들어, 미국 정부 기관인 질병통제예방센터(CDC)의 2024년 5월 자료에 따르면, 2022년 미국에서 심장 질환으로 인한 사망자 수는 70만 2,880명이며, 그 중 37만 1,506명이 관상 동맥 질환으로 인한 사망자입니다. 따라서 심혈관 질환의 발병률이 증가함에 따라 생체 재료 시장에 대한 수요도 증가할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

The biomaterials refer to manmade substances that can be utilized to support tissues or structures in the body. These are natural or synthetic materials that are used in medical applications to support, enhance, or replace damaged tissue or a biological function.

The main types of biomaterials are metallic biomaterial, polymeric biomaterials, natural biomaterials and ceramics. The metallic biomaterials are stainless steels, titanium alloys, and cobalt alloys used to provide internal support to biological tissues. The metallic biomaterials are manmade systems that are utilized in joint replacements, dental implants, orthopedic fixations, and stents to offer internal support to biological tissues. Biomaterials have a wide application in cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering and neurological/central nervous system and are used in hospitals and clinics, ambulatory surgical centers and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the metals and minerals sector, disrupting supply chains for automakers, appliance manufacturers, and infrastructure projects. With reduced competition from imports, domestic mills have increased prices, yet capacity limitations hinder their ability to fully meet demand. At the same time, mining companies are facing challenges from retaliatory tariffs on key mineral exports, especially lithium and rare earth elements. In response, industry participants are ramping up investments in scrap metal recycling, seeking tariff exemptions, and forming joint ventures with international producers to ensure a more reliable supply chain.

The biomaterials market research report is one of a series of new reports from The Business Research Company that provides biomaterials market statistics, including biomaterials industry global market size, regional shares, competitors with a biomaterials market share, detailed biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the biomaterials industry. This biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomaterials market size has grown rapidly in recent years. It will grow from $134.31 billion in 2024 to $151.47 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to growing aging population, adoption of biomaterials in orthopedic and dental applications, increasing awareness of environmental sustainability, increased prevalence of chronic conditions medicine, increased demand for medical implants.

The biomaterials market size is expected to see rapid growth in the next few years. It will grow to $252.41 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to shifting consumer preferences, surge in demand for biomaterials in 3d printing and additive manufacturing, expansion of the biodegradable and bioresorbable biomaterials segment, adoption of biomaterials in drug delivery systems for personalized medicine, increasing use of biomaterials in wound care and tissue regeneration. Major trends in the forecast period include development of smart biomaterials with responsive and adaptive properties, integration of nanotechnology for enhanced functionality, emphasis on precision medicine leading to customized biomaterial solutions, exploration of marine and plant-derived biomaterial sources, collaboration between biomaterial companies and healthcare institutions for innovative applications.

The forecast of 13.6% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through delays in medical device manufacturing and tissue engineering projects, as specialized biomaterial imports from Switzerland and Israel face increased trade barriers, raising costs for healthcare innovation. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of cardiovascular diseases is propelling the expansion of the biomaterials market. Cardiovascular disorders stem from factors such as high blood pressure, smoking, high cholesterol, and inactivity. The rise in cardiovascular disorder cases is largely attributed to noncommunicable diseases like diabetes, chronic respiratory illnesses, coronary artery disease (CAD), and heart attacks related to hypertension. Biomaterials, including heart valves, cardiopulmonary bypass systems, stents, vascular grafts, complete artificial hearts, and pacemakers, serve as healing mechanisms for damaged and diseased heart tissue. For instance, data from the Centers for Disease Control and Prevention (CDC), a US government agency, indicated in May 2024 that there were 702,880 deaths from heart disease in the United States in 2022, with 371,506 of those attributable to coronary artery disease. Consequently, the rising incidence of cardiovascular diseases is expected to boost the demand for the biomaterials market.

The increasing healthcare spending will propel the growth of the biomaterials market. Healthcare spending refers to the total financial resources allocated for medical services, treatments, and healthcare infrastructure within a given period, typically on a national or institutional level. Healthcare spending is used in biomaterials for research and development, product development, procurement and adoption, and regulatory compliance. For instance, in September 2022, according to MedTech Europe, a Belgium-based European trade association representing the medical technology industries, in Europe, on average, approximately 11% of gross domestic product (GDP) is allocated to healthcare. Out of this, about 7. 6% is attributed to medical technologies. The spending on medical technology across European countries ranges from around 5% to 12% of the total healthcare expenditure. The per capita expenditure on medical technology in Europe stands at approximately $346. 08 (€284). Therefore, increasing healthcare spending will contribute to the growth of the biomaterials market.

Strategic partnerships are emerging as a significant trend in the biomaterials market. Leading companies are increasingly focusing on collaborations to develop new implants and combination devices based on biomaterials, leveraging each other's expertise, technology, and resources. These partnerships also aim to boost the adoption of biomaterials. By joining forces, companies can gain a competitive advantage in the market and enhance revenue. For example, in June 2023, IFF, a US-based corporation, launched the Designed Enzymatic Biomaterials (DEB) technology platform to meet the rising demand for sustainable, high-performance materials. This platform enables precise drug delivery through engineered enzymes that release therapeutic agents in response to specific biological cues. It is also vital in tissue engineering, where enzymatic reactions promote tissue regeneration by facilitating cell growth and allowing controlled degradation of scaffolds at predetermined rates. The DEB technology enables the customization of biobased polysaccharides that can match or surpass the performance of traditional petroleum-based polymers, thereby facilitating greater market adoption.

Major companies operating in the biomaterials market focus on technological advancements, such as the designed enzymatic biomaterials (DEB) technology platform, to deliver sustainable biopolymers and gain a competitive advantage. The enzymatic biomaterials (DEB) technology platform involves the use of enzymes to design and modify materials for various applications, including drug delivery, tissue engineering, and diagnostics. For instance, in June 2023, International Flavors & Fragrances Inc., a US-based producer of flavors, fragrances, and cosmetic actives, launched the enzymatic biomaterials technology platform for the development of biobased materials at scale. Designed to deliver meaningful sustainability benefits with performance comparable to or superior to fossil-based materials, DEB technology helps to address growing preferences for environmentally friendly, high-performance biopolymers. The technology platform allows producers to fulfill regulatory changes and increasing consumer demand by replacing traditional fossil-based synthetic polymers.

In October 2024, RTI Surgical (RTI), a US-based medical equipment manufacturing company, acquired Collagen Solutions plc for an undisclosed amount. The objective of RTI Surgical's acquisition of Collagen Solutions is to broaden its soft tissue portfolio and improve its capabilities in the regenerative medicine sector. Collagen Solutions plc is a US-based supplier, developer, and manufacturer of medical-grade collagen, tissues, and other biomaterials for use in regenerative medicine, medical devices, and research.

Major companies operating in the biomaterials market include Corbion N V, Evonik Industries AG, Heraeus Medical Components LLC, Berkeley Advanced Biomaterials Inc., Zimmer Biomet Holdings Inc., DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG, Quattroflow GmbH, Kyocera Corporation, Wright Medical Group NV, KLS Martin Group GmbH & Co KG, Meccellis Biotechnology Co Ltd., Bio-on SpA, Coloplast A/S, Collagen Matrix Inc., IntrinsiQ Materials Inc., PolyActiva Pty Ltd

North America was the largest region in the biomaterials market in 2024. The regions covered in the biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The biomaterials market consists of sales of metals, polymers, and composites. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biomaterials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biomaterials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Biomaterials Market Characteristics

3. Biomaterials Market Trends And Strategies

4. Biomaterials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Biomaterials Growth Analysis And Strategic Analysis Framework

6. Biomaterials Market Segmentation

7. Biomaterials Market Regional And Country Analysis

8. Asia-Pacific Biomaterials Market

9. China Biomaterials Market

10. India Biomaterials Market

11. Japan Biomaterials Market

12. Australia Biomaterials Market

13. Indonesia Biomaterials Market

14. South Korea Biomaterials Market

15. Western Europe Biomaterials Market

16. UK Biomaterials Market

17. Germany Biomaterials Market

18. France Biomaterials Market

19. Italy Biomaterials Market

20. Spain Biomaterials Market

21. Eastern Europe Biomaterials Market

22. Russia Biomaterials Market

23. North America Biomaterials Market

24. USA Biomaterials Market

25. Canada Biomaterials Market

26. South America Biomaterials Market

27. Brazil Biomaterials Market

28. Middle East Biomaterials Market

29. Africa Biomaterials Market

30. Biomaterials Market Competitive Landscape And Company Profiles

31. Biomaterials Market Other Major And Innovative Companies

32. Global Biomaterials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biomaterials Market

34. Recent Developments In The Biomaterials Market

35. Biomaterials Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기